Your browser doesn't support javascript.
loading
Image Gallery: Lenalidomide for the treatment of pseudotumoral herpes simplex virus type 2 infection in human immunodeficiency virus infection.
Gottlieb, J; Janier, M; Battistella, M; Bachelez, H.
Affiliation
  • Gottlieb J; Department of Dermatology, AP-HP Hôpital Saint-Louis, Paris, France.
  • Janier M; Department of Dermatology, AP-HP Hôpital Saint-Louis, Paris, France.
  • Battistella M; Sorbonne Paris Cité Université Paris Diderot, Paris, France.
  • Bachelez H; Department of Pathology, AP-HP Hôpital Saint-Louis, Paris, France.
Br J Dermatol ; 178(1): e63, 2018 01.
Article in En | MEDLINE | ID: mdl-29357582
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Herpes Genitalis / HIV-1 / AIDS-Related Opportunistic Infections / Herpesvirus 2, Human / Lenalidomide Limits: Humans / Male / Middle aged Language: En Journal: Br J Dermatol Year: 2018 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Herpes Genitalis / HIV-1 / AIDS-Related Opportunistic Infections / Herpesvirus 2, Human / Lenalidomide Limits: Humans / Male / Middle aged Language: En Journal: Br J Dermatol Year: 2018 Document type: Article